Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock investors purchased 33,848 call options on the company. This is an increase of 52% compared to the typical volume of 22,258 call options. Insider Buying and Selling at Teva Pharmaceutical Industries In other news, CAO […]